Rights and permissions
About this article
Cite this article
QOL improves after HDC discontinuation in breast cancer. Pharmacoecon. Outcomes News 488, 9 (2005). https://doi.org/10.2165/00151234-200504880-00027
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504880-00027